Seasonal Allergies

Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.

Now FDA approved, Optinose’s Xhance is the first nonsurgical option for chronic rhinosinusitis both with and without nasal polyps.

Another new COVID-19 vaccine, the first and only once-daily amphetamine transdermal patch approved for the treatment of ADHD, and 5 more.

The Asthma and Allergy Foundation of America recently released its annual Allergy Capitals™ report. Which cities are most challenging for patients with seasonal allergies?

What is the optimal duration for immunotherapy? Can intranasal steroids be combined with LRTAs? Test your allergy IQ.

An experimental cell-based therapy induces permanent allergen-specific immunologic tolerance to prevent IgE-mediated allergy.

Why has the number of food allergies increased but overall sensitization to food allergens remained static?

Spring has sprung! Click here for the latest research about some of the more common diseases of the season.

Results of a new study help explain why your adult patients with atopy most likely have autumn birthdays.

Poor agreement between caregiver and children for report of symptoms and relief presents a challenge in clinical trials.